Article Versions Notes

Solares I, Izquierdo-Sánchez L, Morales-Conejo M, Jericó D, Castelbón FJ, Córdoba KM, Sampedro A, Lumbreras C, Moreno-Aliaga MJ, Enríquez de Salamanca R, et al. High Prevalence of Insulin Resistance in Asymptomatic Patients with Acute Intermittent Porphyria and Liver-Targeted Insulin as a Novel Therapeutic Approach. Biomedicines. 2021; 9(3):255. https://doi.org/10.3390/biomedicines9030255

Solares, Isabel, Laura Izquierdo-Sánchez, Montserrat Morales-Conejo, Daniel Jericó, Francisco Javier Castelbón, Karol Marcela Córdoba, Ana Sampedro, Carlos Lumbreras, María Jesús Moreno-Aliaga, Rafael Enríquez de Salamanca, and et al. 2021. "High Prevalence of Insulin Resistance in Asymptomatic Patients with Acute Intermittent Porphyria and Liver-Targeted Insulin as a Novel Therapeutic Approach" Biomedicines 9, no. 3: 255. https://doi.org/10.3390/biomedicines9030255

Solares, I., Izquierdo-Sánchez, L., Morales-Conejo, M., Jericó, D., Castelbón, F. J., Córdoba, K. M., Sampedro, A., Lumbreras, C., Moreno-Aliaga, M. J., Enríquez de Salamanca, R., Berraondo, P., & Fontanellas, A. (2021). High Prevalence of Insulin Resistance in Asymptomatic Patients with Acute Intermittent Porphyria and Liver-Targeted Insulin as a Novel Therapeutic Approach. Biomedicines, 9(3), 255. https://doi.org/10.3390/biomedicines9030255